Chair, Capital Markets and Securities Practice
Vice Chair, Tran
Steven has extensive legal experience focusing on capital markets transactions and securities law matters, representing public companies, investment banks, and investors. Steven also handles strategic mergers and acquisitions, representing both public and private companies.
When managing public and private securities offerings, Steven identifies and mitigates potential roadblocks, ensuring that transactions move forward quickly. Issuers, underwriters, and investors all appreciate Steven's informed perspective, diplomacy, and ability to expedite transactions.
Steven's involvement with capital markets transactions touches upon nearly every industry sector. He frequently handles IPO transactions, follow-up public offering deals, CMPO transactions, Special Purpose Acquisition Companies (SPACs), registered direct offerings, ATMs, PIPE deals, convertible equity transactions, and debt offerings.
Steven's track record of success in the life sciences sector makes him an essential team player for life sciences transactions. He works with leading investment banks that concentrate in this industry, deftly handling public offerings of biopharmaceuticals and medical technology companies, as well as other transactions.
Steven often serves as an advisor to corporate companies and their boards on matters such as SEC compliance, disclosure issues, and corporate governance. He also counsels clients on federal securities law, as well as rules and regulations pertaining to the Financial Industry Regulatory Authority, Nasdaq, and the New York Stock Exchange.
Principal areas of focus include:
Capital Markets & Securities | Corporate | Corporate Finance & Securities | Life Sciences | Mergers & Acquisitions | PIPEs & Registered Direct Offerings | Pipes, Spacs & Registered Direct Offerings | Private Equity | Private Equity & Mezzanine Financing | Transactions & Advisory Group
Represented Laidlaw & Company (UK), the sole underwriter, in the $7 million public offering for ContraVir Pharmaceuticals.
Represented Maxim Group, the lead underwriter and representative to CRT Capital Group and Rodman & Renshaw (a unit of H.C. Wainwright & Co.), in the $4.3 million public offering for BioPharmX Corporation (NYSE MKT: BPMX).
Represented Matinas BioPharma Holdings Inc. in connection with a $10 million private placement.
Represented ROTH Capital Partners in its $25 million offering of preferred stock for RMG Networks Holding Corp.
Represented Roka Bioscience Inc. in connection with its $60 million initial public offering led by Bank of America and Leerink Partners.
Represented Matinas BioPharma Holdings Inc. in connection with its merger with Aquarius Biotechnologies.
Represented Wedbush PacGrow Life Sciences as sole manager in connection with the $13 million public offering of AxoGen Inc.
Represented Ladenburg Thalmann & Co. in a $40 million public offering issued by Aastrom Biosciences Inc.
Represented Cowen and Company as underwriter in connection with a $22.4 million public offering by Plug Power.
Represented Ladenburg Thalmann & Co. in a $15 million public offering for ParkerVision.
Represented Arotech Corporation in connection with its acquisition of all of the membership interests of UEC Electronics.
Represented Arotech Corporation in connection with its $11.5 million public offering.
Represented ROTH Capital Partners as underwriters in connection with the public offering by NTN Buzztime, resulting in gross proceeds of approximately $7 million.
Represented Maxim Group in a $29.2 million Series B financing of Centrexion Corporation.
Represented ROTH Capital Partners as underwriter in connection with the $42.9 million public offering of RMG Networks.
Represented ROTH Capital Partners as placement agent in the $4 million registered direct offering by Mines Management Inc.
Represented Needham & Company LLC as underwriter in connection with the $20 million public offering of Anadigics.
Represented Needham & Company LLC and Craig-Halum Capital Group as underwriters in connection with the $20.4 million public offering of Sequans Communications.
Represented Maxim Group as placement agent in connection with the $11 million private placement of Premier Alliance.
Represented Needham & Company LLC as underwriter in connection with the $15 million public offering of Sequans Communications.
Represented Laidlaw & Company (UK) as placement agent counsel in connection with the $7.79 million private placement in Aldeyra Therapeutics.
Represented Metalico Inc. in connection with a restructuring of its major institutional debt. The transaction included an equity conversion of $10 million of the company's outstanding convertible notes, as well as an exchange of approximately $14 million of outstanding principal amount of such notes for new ten-year convertible notes in the principal amount of approximately $14 million and rights to additional shares of the company's common stock.
Lowenstein Sandler was a Diamond sponsor of the 2016 28th Annual ROTH Conference. The event was a four-day conference that hosted 500 companies and 4,000 attendees, including institutional investors, private equity investors, VCs, company executives, and service providers working in the small and mid-cap space. In conjunction with the firm's sponsorship, we hosted the Keynote Presentation on Sunday, March 13, in which Michael Lerner introduced the keynote speaker, J. Craig Venter, Ph.D. We also hosted the Private Company Track on Tuesday, March 15, in which Jack Hogoboom and Steve Skolnick participated on a panel entitled "IPO Readiness." The panel reviewed the current market conditions, discussed the IPO market, and provided key insights for companies seeking public financing. To view the full video of the "IPO Readiness" panel, please click here.
Lawyers Steven Siesser, Jack Hogoboom, Michael Lerner, Steven Skolnick, Kate Basmagian, Sarah Saladini, Neeraj Kumar, and James O'Grady attended the conference.
Lowenstein Sandler is a sponsor of the 7th Annual ROTH Deer Valley Corporate Access Event which will be held at the Montage Deer Valley Resort in Park City, Utah.
Note: Attendance is by invitation only and is not open to the public.
Location: Montage Deer Valley Resort, 9100 Marsac Avenue Park City, UT 84060
Lowenstein Sandler is a sponsor of the 31st Annual ROTH Conference which will be held at The Ritz Carlton, Laguna Niguel in Orange County, CA.
Note: Attendance is by invitation only and is not open to the public.
Location: The Ritz Carlton, 888 San Clemente Drive, Newport Beach, CA 92660
Lowenstein Sandler is a bronze sponsor of the 2019 Gateway Conference. An annual invite-only conference that brings together the most compelling companies with the nation’s top investors and analysts. Featuring companies from a number of industries, including tech, business services, consumer, digital media, cleantech, life sciences, and financial services. The format has been designed to give attendees direct access to senior management via company presentations, Q&A sessions, and one-on-one meetings.
On April 5, 2012, President Barack Obama signed into law the Jumpstart Our Business Startups Act, or JOBS Act. The JOBS Act was designed to improve access to the U.S. capital markets for smaller businesses, and it instructed the U.S. Securities and Exchange Commission (SEC) to amend the securities laws and conduct studies on capital formation, disclosure and registration requirements.
© Lowenstein Sandler LLP, 2020